Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 238
interventional 187
Observational 49
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 110
Biological 17
Biological|Drug 12
Drug|placebo 11
Other 6
Biological|Drug|Procedure 4
Device 4
Biological|Drug|Procedure|Radiation 3
Drug|Other 2
Drug|Other|Procedure|Radiation 2
Drug|Procedure|Radiation 2
Behavioral 1
Behavioral|Drug|placebo 1
Biological|Device|Drug 1
Biological|Drug|placebo 1
Biological|placebo 1
Diagnostic Test 1
Dietary Supplement 1
Dietary Supplement|Drug 1
Dietary Supplement|placebo 1
Drug|placebo|Procedure 1
Drug|Procedure 1
Genetic 1
Other|Procedure 1
Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 67
NA 22
China 20
France 7
Korea, Republic of 7
Netherlands 5
Brazil 4
Australia 3
Canada 3
Germany 3
Japan 3
Belgium 2
Botswana 2
China|Ukraine 2
India 2
Russian Federation 2
Spain 2
United States|Canada 2
United States|China|Russian Federation|Ukraine 2
Belarus 1
Brazil|India|Mexico|Romania|Russian Federation|Ukraine 1
Bulgaria|Georgia|Germany|Hungary|Poland|Ukraine 1
Bulgaria|Romania|Russian Federation|Serbia|Ukraine 1
Czech Republic|Hungary|Latvia|Russian Federation|Slovakia|Ukraine 1
Germany|Italy|Spain 1
Indonesia 1
Iran, Islamic Republic of 1
Italy 1
Mexico 1
Slovakia 1
South Africa 1
Switzerland 1
Taiwan 1
Thailand 1
Turkey 1
United States|Argentina|Brazil|Chile|Colombia|Finland|Mexico|Pakistan|Peru|Venezuela| 1
United States|Argentina|Chile|India|Malaysia|Puerto Rico|Russian Federation|Spain 1
United States|Australia|Belgium|Bulgaria|Canada|Czechia|France|Hungary|Ireland|Italy|Latvia|Mexico|Poland|Romania|Russian Federation|Slovakia|Ukraine 1
United States|Australia|Canada|Netherlands|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|Canada|Puerto Rico|Switzerland 1
United States|Australia|Czechia|Georgia|Hungary|Israel|Poland 1
United States|Bulgaria|Croatia|Hungary|Poland|Romania|Russian Federation|Ukraine 1
United States|Canada|Puerto Rico 1
United States|Honduras 1
United States|India 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 125
2 9
3 4
5 6
6 7
7 3
9 2
11 2
12 1
13 2
15 1
19 1
21 1
22 2
23 1
25 1
26 1
31 2
33 1
36 1
40 1
41 1
45 1
49 2
53 1
60 1
64 1
83 1
84 1
154 1
160 1
179 1
235 1

Phase

Phase Study_Count
Phase 2 54
Phase 3 42
Phase 1 27
Phase 4 25
N/A 20
Phase 1/Phase 2 14
Phase 2/Phase 3 5

Number of Arms

Number_of_Arms Count_of_Studies
1 38
2 74
3 23
4 12
5 1
6 3
7 1
8 1
16 1
NA 33

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 25.0000 3.00 1 5.0000 10.0 10.0000 12.00
1st Qu. 60.0000 24.00 18 39.5000 19.0 114.0000 75.00
Median 117.0000 33.00 25 75.0000 22.0 196.0000 157.00
Mean 379.7647 47.64 26 161.8431 112.4 258.2439 361.76
3rd Qu. 200.0000 64.00 37 137.5000 177.0 330.0000 324.00
Max. 3960.0000 153.00 49 3724.0000 334.0 928.0000 2252.00

Trial Group Type

group_type Group_Count
Experimental 234
Active Comparator 76
NA 33
Placebo Comparator 22
Other 16
No Intervention 8
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 100
Single Group Assignment 51
NA 23
Crossover Assignment 8
Sequential Assignment 4
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 105
Supportive Care 37
Prevention 28
Diagnostic 5
Other 4
Basic Science 3
Health Services Research 3
NA 2

Observational Studies

Studies by Country

Country Study_Count
United States 10
France 9
NA 6
Spain 3
Egypt 2
Germany 2
Switzerland 2
Taiwan 2
Austria|Australia|Canada|France|Germany|Greece|Ireland|Italy|Poland|Romania|Spain 1
Austria|Belgium|Bulgaria|Czechia|France|Germany|Greece|Poland|Romania 1
Austria|Belgium|Czech Republic|France|Germany|Hungary|Italy|Poland|Romania|Spain|Switzerland|United Kingdom 1
Belgium 1
Canada 1
China 1
Israel 1
Italy 1
Korea, Republic of 1
Turkey 1
United Kingdom 1
United States|Canada|Israel|Singapore|United Kingdom 1
United States|Canada|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 32
2 1
3 2
5 2
6 1
9 1
17 1
20 1
28 1
52 1
64 1
75 1
84 1
87 1
90 1
120 1

Enrollment Metrics

Measure Observational
Min 20.00
1st Qu 84.00
Median 200.00
Mean 2501.98
3rd Qu 610.00
Max 100000.00

Observation Model

observational_model Study_Count
Cohort 26
Case-Only 16
Other 4
Case-Crossover 1
Case Control 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 39
Retrospective 6
Other 3
NA 1

Registries

Studies by Country

Country Study_Count
Korea, Republic of 1
United States 1

Sites per Study

Site_count Study_Count
1 1
24 1

Enrollment Metrics

Measure Registries
Min 1000
1st Qu 1179
Median 1358
Mean 1358
3rd Qu 1537
Max 1716

Registry Model

observational_model Study_Count
Cohort 2

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
10 Years 1
36 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03823950 Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients https://ClinicalTrials.gov/show/NCT03823950 Recruiting University of Mississippi Medical Center 2021-12-31
NCT03333486 Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer https://ClinicalTrials.gov/show/NCT03333486 Recruiting Roswell Park Cancer Institute 2022-09-06
NCT03333005 Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia https://ClinicalTrials.gov/show/NCT03333005 Completed Amplyx Pharmaceuticals 2018-10-26
NCT03314805 PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy https://ClinicalTrials.gov/show/NCT03314805 Recruiting PhytoHealth Corporation 2020-12-31
NCT03294577 Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia https://ClinicalTrials.gov/show/NCT03294577 Recruiting BeyondSpring Pharmaceuticals Inc. 2020-06-15
NCT03252431 Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy https://ClinicalTrials.gov/show/NCT03252431 Active, not recruiting Generon (Shanghai) Corporation Ltd. 2019-09-25
NCT03251768 Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients https://ClinicalTrials.gov/show/NCT03251768 Completed Tianjin SinoBiotech Ltd. 2018-07-23
NCT03246009 Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients https://ClinicalTrials.gov/show/NCT03246009 Completed Tianjin SinoBiotech Ltd. 2017-04-10
NCT03233776 Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT https://ClinicalTrials.gov/show/NCT03233776 Active, not recruiting Radboud University 2019-05-07
NCT03208816 Community-Led Action Research in Oncology: Improving Symptom Management https://ClinicalTrials.gov/show/NCT03208816 Completed Dartmouth-Hitchcock Medical Center 2017-12-31
NCT03182465 Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia https://ClinicalTrials.gov/show/NCT03182465 Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2020-08-25
NCT03104595 Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer https://ClinicalTrials.gov/show/NCT03104595 Recruiting Enzychem Lifesciences Corporation 2018-12-31
NCT03102606 Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 https://ClinicalTrials.gov/show/NCT03102606 Recruiting BeyondSpring Pharmaceuticals Inc. 2020-06-01
NCT03087227 Shared Health Information System for Febrile Neutropenia https://ClinicalTrials.gov/show/NCT03087227 Recruiting University of Paris 13 2019-11-30
NCT03078010 Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03078010 Recruiting Memorial Sloan Kettering Cancer Center 2021-02-28
NCT03019939 Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia https://ClinicalTrials.gov/show/NCT03019939 Active, not recruiting M.D. Anderson Cancer Center 2020-03-01
NCT02953340 SPI-2012 vs Pegfilgrastim in Management of Neutropenia in BReast Cancer Patients With Docetaxel and Cyclophosphamide https://ClinicalTrials.gov/show/NCT02953340 Completed Spectrum Pharmaceuticals, Inc 2017-08-27
NCT02872103 Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy https://ClinicalTrials.gov/show/NCT02872103 Completed Generon (Shanghai) Corporation Ltd. 2017-12-20
NCT02816112 Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia https://ClinicalTrials.gov/show/NCT02816112 Completed Ottawa Hospital Research Institute 2020-03-31
NCT02805205 PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia https://ClinicalTrials.gov/show/NCT02805205 Completed CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 2016-02-29
NCT02778763 Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis https://ClinicalTrials.gov/show/NCT02778763 Completed BioLab 612 LLC 2016-07-31
NCT02755857 Bioavailability Study of Lozanocâ„¢ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis https://ClinicalTrials.gov/show/NCT02755857 Completed Mayne Pharma International Pty Ltd 2016-12-31
NCT02728596 S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) https://ClinicalTrials.gov/show/NCT02728596 Recruiting Southwest Oncology Group 2021-04-30
NCT02700360 Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers https://ClinicalTrials.gov/show/NCT02700360 Completed Enzychem Lifesciences Corporation 2015-10-31
NCT02692742 Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia https://ClinicalTrials.gov/show/NCT02692742 Completed Myelo Therapeutics GmbH 2017-11-30
NCT02679443 Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy https://ClinicalTrials.gov/show/NCT02679443 Completed Postgraduate Institute of Medical Education and Research 2016-12-31
NCT02643901 Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects https://ClinicalTrials.gov/show/NCT02643901 Completed Jiangsu T-Mab Biopharma Co.,Ltd 2016-10-10
NCT02643420 SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Breast CANCEr Patients With Docetaxel and Cyclophosphamide https://ClinicalTrials.gov/show/NCT02643420 Completed Spectrum Pharmaceuticals, Inc 2017-08-18
NCT02629289 A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants https://ClinicalTrials.gov/show/NCT02629289 Completed Pfizer 2016-06-30
NCT02621905 Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg https://ClinicalTrials.gov/show/NCT02621905 Completed Mayne Pharma International Pty Ltd 2016-11-30
NCT02589301 Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations https://ClinicalTrials.gov/show/NCT02589301 Completed Eurofarma Laboratorios S.A. 2016-03-31
NCT02231879 Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome https://ClinicalTrials.gov/show/NCT02231879 Active, not recruiting National Institutes of Health Clinical Center (CC) 2020-10-05
NCT00967785 A Phase I Study of Mozobil in the Treatment of Patients With WHIMS https://ClinicalTrials.gov/show/NCT00967785 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT02544685 Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients https://ClinicalTrials.gov/show/NCT02544685 Active, not recruiting S&D Pharma SK s.r.o. 2019-09-30
NCT02532712 Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers https://ClinicalTrials.gov/show/NCT02532712 Completed Enzychem Lifesciences Corporation 2015-12-31
NCT02527746 Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy https://ClinicalTrials.gov/show/NCT02527746 Completed Generon (Shanghai) Corporation Ltd. 2013-12-31
NCT02522234 A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy https://ClinicalTrials.gov/show/NCT02522234 Completed Generon (Shanghai) Corporation Ltd. 2015-08-19
NCT02521441 A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy. https://ClinicalTrials.gov/show/NCT02521441 Completed Generon (Shanghai) Corporation Ltd. 2015-09-20
NCT02496143 A Safety and PK Study of EC-18 in Healthy Subjects https://ClinicalTrials.gov/show/NCT02496143 Completed Enzychem Lifesciences Corporation 2015-12-31
NCT02467868 Efficacy and Safety Study With MYL-1401H and Neulasta https://ClinicalTrials.gov/show/NCT02467868 Completed Mylan Inc. 2015-09-30
NCT02465801 Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein https://ClinicalTrials.gov/show/NCT02465801 Completed Tianjin SinoBiotech Ltd. 2015-12-23
NCT02452034 Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097) https://ClinicalTrials.gov/show/NCT02452034 Completed Merck Sharp & Dohme Corp. 2018-06-26
NCT02414581 Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% https://ClinicalTrials.gov/show/NCT02414581 Completed Hospital Regional de Alta Especialidad del Bajio 2016-08-31
NCT02404155 Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN) https://ClinicalTrials.gov/show/NCT02404155 Active, not recruiting University of Maryland, Baltimore 2020-04-30
NCT02282215 Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02282215 Completed Cellerant Therapeutics 2017-09-22
NCT02251977 Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer https://ClinicalTrials.gov/show/NCT02251977 Completed Sun Yat-sen University 2017-09-05
NCT02213783 Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT02213783 Completed Prince of Songkla University 2013-07-31
NCT02190721 A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement https://ClinicalTrials.gov/show/NCT02190721 Completed Teva Pharmaceutical Industries 2017-04-04
NCT02179359 Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies https://ClinicalTrials.gov/show/NCT02179359 Recruiting Masonic Cancer Center, University of Minnesota 2020-08-31
NCT02156388 Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors https://ClinicalTrials.gov/show/NCT02156388 Completed Jiangsu T-Mab Biopharma Co.,Ltd 2015-02-28
NCT02149329 Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO https://ClinicalTrials.gov/show/NCT02149329 Completed VU University Medical Center 2019-08-05
NCT02119715 A Phase II Study Comparing Pegylated rhG-CSF(HHPG-19K) and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT02119715 Completed Jiangsu HengRui Medicine Co., Ltd. 2012-08-31
NCT02104830 Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients https://ClinicalTrials.gov/show/NCT02104830 Completed Biocad 2014-06-30
NCT01307579 Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01307579 Active, not recruiting Children’s Oncology Group 2018-06-30
NCT02044276 A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia https://ClinicalTrials.gov/show/NCT02044276 Completed Teva Pharmaceutical Industries 2017-08-29
NCT02005783 Study of Danggui Buxue Decoction in Preventing Neutropenia https://ClinicalTrials.gov/show/NCT02005783 Completed Shanghai Jiao Tong University School of Medicine 2015-08-31
NCT02005458 Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT02005458 Completed Xiamen Amoytop Biotech Co., Ltd. 2017-03-31
NCT01974401 Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia https://ClinicalTrials.gov/show/NCT01974401 Completed Mashhad University of Medical Sciences 2011-03-31
NCT01966367 CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01966367 Active, not recruiting Columbia University 2022-01-31
NCT01923545 Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia https://ClinicalTrials.gov/show/NCT01923545 Completed Dong-A ST Co., Ltd. 2011-05-31
NCT01919710 Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia https://ClinicalTrials.gov/show/NCT01919710 Completed Tianjin SinoBiotech Ltd. 2014-06-30
NCT01917708 Bone Marrow Transplant With Abatacept for Non-Malignant Diseases https://ClinicalTrials.gov/show/NCT01917708 Completed Emory University 2019-09-19
NCT01916057 Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis https://ClinicalTrials.gov/show/NCT01916057 Completed Assistance Publique - Hôpitaux de Paris 2017-06-01
NCT01852370 Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases https://ClinicalTrials.gov/show/NCT01852370 Enrolling by invitation University of Pittsburgh 2023-11-30
NCT01735175 Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® https://ClinicalTrials.gov/show/NCT01735175 Completed Sandoz 2013-05-31
NCT01724866 Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients https://ClinicalTrials.gov/show/NCT01724866 Completed Spectrum Pharmaceuticals, Inc 2014-12-31
NCT01714570 Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia https://ClinicalTrials.gov/show/NCT01714570 Completed Chinese PLA General Hospital 2014-03-31
NCT01674855 Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia https://ClinicalTrials.gov/show/NCT01674855 Completed Dong-A ST Co., Ltd. 2013-02-28
NCT01649635 Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT01649635 Completed Sanofi 2014-01-31
NCT01648322 Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy https://ClinicalTrials.gov/show/NCT01648322 Completed Generon (Shanghai) Corporation Ltd. 2014-12-31
NCT01629082 Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01629082 Completed National Institutes of Health Clinical Center (CC) 2015-10-27
NCT01611051 A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT01611051 Completed Jiangsu HengRui Medicine Co., Ltd. 2013-01-31
NCT01581333 Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia https://ClinicalTrials.gov/show/NCT01581333 Completed Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2016-05-31
NCT01569087 Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer https://ClinicalTrials.gov/show/NCT01569087 Completed Biocad 2013-01-31
NCT01529827 Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01529827 Completed Roswell Park Cancer Institute 2015-05-28
NCT01519700 Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim https://ClinicalTrials.gov/show/NCT01519700 Completed Sandoz 2013-06-30
NCT01516736 Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim https://ClinicalTrials.gov/show/NCT01516736 Completed Sandoz 2013-08-31
NCT01484015 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT01484015 Completed Wake Forest University Health Sciences 2012-06-30
NCT01401010 Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients https://ClinicalTrials.gov/show/NCT01401010 Completed Michigan State University 2012-02-29
NCT01375608 Decitabine for High-Risk Sickle Cell Disease https://ClinicalTrials.gov/show/NCT01375608 Completed National Institutes of Health Clinical Center (CC) 2015-12-31
NCT01371656 Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01371656 Completed Children’s Oncology Group 2017-06-30
NCT01344681 Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases https://ClinicalTrials.gov/show/NCT01344681 Completed Yonsei University 2014-03-31
NCT01328938 GCPGC in Chemotherapy-induced Neutropenia https://ClinicalTrials.gov/show/NCT01328938 Completed Green Cross Corporation 2012-11-30
NCT04345900 Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 https://ClinicalTrials.gov/show/NCT04345900 Completed BeyondSpring Pharmaceuticals Inc. 2018-03-20
NCT04233996 Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients https://ClinicalTrials.gov/show/NCT04233996 Recruiting Hospital Universitari de Bellvitge 2021-06-30
NCT04227990 Plinabulin iv Solution in Prevention of TAC Induced Neutropenia https://ClinicalTrials.gov/show/NCT04227990 Completed BeyondSpring Pharmaceuticals Inc. 2018-10-15
NCT04187898 Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer https://ClinicalTrials.gov/show/NCT04187898 Recruiting Spectrum Pharmaceuticals, Inc 2020-10-30
NCT04187755 Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever https://ClinicalTrials.gov/show/NCT04187755 Completed Indonesia University 2019-07-31
NCT04171986 Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis https://ClinicalTrials.gov/show/NCT04171986 Recruiting Tianjin Medical University Cancer Institute and Hospital 2021-10-31
NCT04138251 Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency https://ClinicalTrials.gov/show/NCT04138251 Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2020-06-30
NCT04101760 Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer https://ClinicalTrials.gov/show/NCT04101760 Recruiting Peking Union Medical College Hospital 2020-10-01
NCT04099901 Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT04099901 Recruiting Radboud University 2021-10-31
NCT04083079 Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma https://ClinicalTrials.gov/show/NCT04083079 Recruiting Ruijin Hospital 2021-08-01
NCT04081753 Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy https://ClinicalTrials.gov/show/NCT04081753 Recruiting Augusta University 2020-04-30
NCT00837265 Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel https://ClinicalTrials.gov/show/NCT00837265 Completed Teva Pharmaceutical Industries 2009-09-30
NCT03768869 Fever and Neutropenia in Pediatric Oncology Patients https://ClinicalTrials.gov/show/NCT03768869 Active, not recruiting University of Colorado, Denver 2009-04-03
NCT03740464 Long-acting G-CSF for Febrile Neutropenia https://ClinicalTrials.gov/show/NCT03740464 Recruiting Peking Union Medical College Hospital 2019-11-10
NCT03674294 Aprepitant Triple Therapy Caused Chemotherapy Induced Nausea And Vomiting In Gastrointestinal Tumors https://ClinicalTrials.gov/show/NCT03674294 Recruiting Sun Yat-sen University 2019-12-29
NCT03619252 Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents https://ClinicalTrials.gov/show/NCT03619252 Enrolling by invitation Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 2020-05-31
NCT03513328 Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation https://ClinicalTrials.gov/show/NCT03513328 Recruiting University of Florida 2021-06-30
NCT03427593 Severe PID With Lymphoproliferation and Neutropenia https://ClinicalTrials.gov/show/NCT03427593 Completed University Hospital, Strasbourg, France 2018-03-13
NCT01229761 Study to Improve Survival Among HIV-Exposed Infants in Botswana https://ClinicalTrials.gov/show/NCT01229761 Completed Harvard School of Public Health 2015-03-31
NCT01200355 Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT01200355 Completed Memorial Sloan Kettering Cancer Center 2017-04-20
NCT01193283 Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia https://ClinicalTrials.gov/show/NCT01193283 Completed National Institutes of Health Clinical Center (CC) 2014-09-30
NCT01187017 A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia https://ClinicalTrials.gov/show/NCT01187017 Completed National Institutes of Health Clinical Center (CC) 2012-07-31
NCT01164215 Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy https://ClinicalTrials.gov/show/NCT01164215 Completed UNC Lineberger Comprehensive Cancer Center 2012-11-30
NCT01126190 Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel (NEUGR-003) https://ClinicalTrials.gov/show/NCT01126190 Completed Teva Pharmaceutical Industries 2012-02-29
NCT01107756 A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen https://ClinicalTrials.gov/show/NCT01107756 Completed Sanofi 2012-07-31
NCT01086878 Safety of Cotrimoxazole in HIV- and HAART-exposed Infants https://ClinicalTrials.gov/show/NCT01086878 Completed Harvard School of Public Health 2010-10-31
NCT00928291 Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile Neutropenia https://ClinicalTrials.gov/show/NCT00928291 Completed Federal University of Minas Gerais 2011-04-30
NCT00911170 PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study https://ClinicalTrials.gov/show/NCT00911170 Completed Amgen 2012-09-17
NCT03793205 G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients https://ClinicalTrials.gov/show/NCT03793205 Recruiting Peking Union Medical College Hospital 2020-01-01
NCT00855309 Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia https://ClinicalTrials.gov/show/NCT00855309 Completed Wake Forest University Health Sciences 2013-11-30
NCT01114165 Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients https://ClinicalTrials.gov/show/NCT01114165 Completed University Hospital Muenster 2012-09-30
NCT01079676 A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer https://ClinicalTrials.gov/show/NCT01079676 Completed Eurofarma Laboratorios S.A. 2011-04-30
NCT02766647 A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) https://ClinicalTrials.gov/show/NCT02766647 Completed Pfizer 2016-02-29
NCT02766634 A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) https://ClinicalTrials.gov/show/NCT02766634 Completed Pfizer 2016-06-30
NCT02816164 A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia https://ClinicalTrials.gov/show/NCT02816164 Completed Ottawa Hospital Research Institute 2019-02-28
NCT04000711 Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT04000711 Completed Hospital Infantil de Mexico Federico Gomez 2017-09-30
NCT00784368 A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection https://ClinicalTrials.gov/show/NCT00784368 Completed Janssen Pharmaceutical K.K. 2009-04-30
NCT00776165 Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF) https://ClinicalTrials.gov/show/NCT00776165 Completed Shantha Biotechnics Limited 2009-07-31
NCT00771810 Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer https://ClinicalTrials.gov/show/NCT00771810 Completed Tarix Pharmaceuticals 2011-12-31
NCT00771433 G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer https://ClinicalTrials.gov/show/NCT00771433 Completed National Cancer Institute (NCI) 2011-05-31
NCT00770172 G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT00770172 Completed National Cancer Institute (NCI) 2011-05-31
NCT00730314 Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells https://ClinicalTrials.gov/show/NCT00730314 Completed Children’s Hospital Los Angeles 2015-08-31
NCT00709358 Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections https://ClinicalTrials.gov/show/NCT00709358 Completed Assistance Publique - Hôpitaux de Paris 2010-09-30
NCT00686543 Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) https://ClinicalTrials.gov/show/NCT00686543 Completed Merck Sharp & Dohme Corp. 2009-04-30
NCT00627393 Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) https://ClinicalTrials.gov/show/NCT00627393 Completed HealthCore-NERI 2013-04-30
NCT00608738 Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment https://ClinicalTrials.gov/show/NCT00608738 Completed Northwestern University 2005-01-31
NCT00548080 Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) https://ClinicalTrials.gov/show/NCT00548080 Completed Merck Sharp & Dohme Corp. 2006-11-30
NCT00541125 G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer https://ClinicalTrials.gov/show/NCT00541125 Completed Federation Francophone de Cancerologie Digestive 2013-09-30
NCT00536081 Various G-CSF Regimens to Prevent Infection During Chemotherapy https://ClinicalTrials.gov/show/NCT00536081 Completed Academisch Ziekenhuis Maastricht 2009-12-31
NCT00497809 Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia https://ClinicalTrials.gov/show/NCT00497809 Completed AviGenics 2008-07-31
NCT00454272 Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients https://ClinicalTrials.gov/show/NCT00454272 Completed Sanofi 2007-08-31
NCT00020371 BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy https://ClinicalTrials.gov/show/NCT00020371 Completed National Cancer Institute (NCI) NA
NCT01058993 AMD 3100 for Treatment of Myelokathexis https://ClinicalTrials.gov/show/NCT01058993 Completed University of Washington 2011-03-31
NCT00392951 Sirolimus for Autoimmune Disease of Blood Cells https://ClinicalTrials.gov/show/NCT00392951 Completed Children’s Hospital of Philadelphia 2016-02-29
NCT00379964 A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) https://ClinicalTrials.gov/show/NCT00379964 Completed Merck Sharp & Dohme Corp. 2006-05-31
NCT00364468 Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients https://ClinicalTrials.gov/show/NCT00364468 Completed Kyowa Kirin Co., Ltd. 2008-03-31
NCT00352300 Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer https://ClinicalTrials.gov/show/NCT00352300 Completed Gynecologic Oncology Group 2010-07-31
NCT00335478 Daptomycin in Treating Neutropenia and Fever in Patients With Cancer https://ClinicalTrials.gov/show/NCT00335478 Completed OHSU Knight Cancer Institute 2008-10-31
NCT00305708 Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission https://ClinicalTrials.gov/show/NCT00305708 Completed University of California, San Francisco 2004-07-31
NCT00301834 Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders https://ClinicalTrials.gov/show/NCT00301834 Completed University of California, San Francisco 2011-09-30
NCT00295971 Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease https://ClinicalTrials.gov/show/NCT00295971 Completed University of California, San Francisco 2011-12-31
NCT00292071 Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) https://ClinicalTrials.gov/show/NCT00292071 Completed Merck Sharp & Dohme Corp. 2006-07-31
NCT00277160 A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer https://ClinicalTrials.gov/show/NCT00277160 Completed Amgen 2004-11-30
NCT00260689 Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia https://ClinicalTrials.gov/show/NCT00260689 Completed National Institutes of Health Clinical Center (CC) 2016-05-04
NCT00257790 The Tobramycin Study https://ClinicalTrials.gov/show/NCT00257790 Completed Oslo University Hospital NA
NCT00213759 Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF https://ClinicalTrials.gov/show/NCT00213759 Completed University Hospital, Strasbourg, France NA
NCT00176878 Stem Cell Transplant for Bone Marrow Failure Syndromes https://ClinicalTrials.gov/show/NCT00176878 Completed Masonic Cancer Center, University of Minnesota 2009-03-31
NCT00176852 Stem Cell Transplant for Hemoglobinopathy https://ClinicalTrials.gov/show/NCT00176852 Completed Masonic Cancer Center, University of Minnesota 2014-03-31
NCT00174473 A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children https://ClinicalTrials.gov/show/NCT00174473 Completed Pfizer NA
NCT02324231 SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia https://ClinicalTrials.gov/show/NCT02324231 Completed Swiss Pediatric Oncology Group 2018-09-15
NCT00138736 Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia https://ClinicalTrials.gov/show/NCT00138736 Completed Sanquin Plasma Products BV NA
NCT00137787 Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases https://ClinicalTrials.gov/show/NCT00137787 Completed Center for Supporting Hematology-Oncology Trials 2009-12-31
NCT00129688 Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children https://ClinicalTrials.gov/show/NCT00129688 Completed Khon Kaen University NA
NCT00125723 FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy https://ClinicalTrials.gov/show/NCT00125723 Completed Amgen 2005-12-31
NCT00115414 Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) https://ClinicalTrials.gov/show/NCT00115414 Completed Amgen NA
NCT00004215 Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00004215 Completed Memorial Sloan Kettering Cancer Center 2000-08-31
NCT00002665 SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT00002665 Completed Southwest Oncology Group 2001-12-31
NCT00004192 Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00004192 Completed University of Nebraska 2001-02-28
NCT00082537 MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) https://ClinicalTrials.gov/show/NCT00082537 Completed Merck Sharp & Dohme Corp. 2006-10-31
NCT00002719 Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00002719 Completed European Organisation for Research and Treatment of Cancer - EORTC 2001-11-30
NCT00002866 Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer https://ClinicalTrials.gov/show/NCT00002866 Completed Canadian Cancer Trials Group 2005-07-19
NCT00002800 Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00002800 Completed Memorial Sloan Kettering Cancer Center 2003-03-31
NCT00002759 Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma https://ClinicalTrials.gov/show/NCT00002759 Completed National Cancer Institute (NCI) 2002-04-30
NCT00077311 Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00077311 Completed Alliance for Clinical Trials in Oncology 2006-07-31
NCT00068471 Anidulafungin in Treating Immunocompromised Children With Neutropenia https://ClinicalTrials.gov/show/NCT00068471 Completed National Cancer Institute (NCI) NA
NCT00008359 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment https://ClinicalTrials.gov/show/NCT00008359 Completed Memorial Sloan Kettering Cancer Center 2003-03-31
NCT00066599 Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy https://ClinicalTrials.gov/show/NCT00066599 Completed National Cancer Institute (NCI) NA
NCT00002643 Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing’s Sarcoma or Primitive Neuroectodermal Tumor https://ClinicalTrials.gov/show/NCT00002643 Completed National Cancer Institute (NCI) 2003-06-30
NCT00002693 Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia https://ClinicalTrials.gov/show/NCT00002693 Completed Mayo Clinic 2006-04-30
NCT00031980 Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer https://ClinicalTrials.gov/show/NCT00031980 Completed Alliance for Clinical Trials in Oncology 2005-05-31
NCT00020527 Caspofungin Acetate in Treating Children With Fever and Neutropenia https://ClinicalTrials.gov/show/NCT00020527 Completed National Cancer Institute (NCI) NA
NCT00003739 Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy https://ClinicalTrials.gov/show/NCT00003739 Completed Children’s Oncology Group 2002-12-31
NCT00001790 Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia https://ClinicalTrials.gov/show/NCT00001790 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001646 Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis https://ClinicalTrials.gov/show/NCT00001646 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001533 Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine https://ClinicalTrials.gov/show/NCT00001533 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001338 A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer https://ClinicalTrials.gov/show/NCT00001338 Completed National Institutes of Health Clinical Center (CC) NA
NCT00044486 Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899) https://ClinicalTrials.gov/show/NCT00044486 Completed Merck Sharp & Dohme Corp. 2004-12-31
NCT00035620 Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT00035620 Completed Amgen 2007-01-31
NCT00035594 Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT00035594 Completed Amgen 2004-02-29
NCT00056381 Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17 https://ClinicalTrials.gov/show/NCT00056381 Completed Pfizer NA
NCT00035425 Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection https://ClinicalTrials.gov/show/NCT00035425 Completed Pfizer NA
NCT00002263 A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine https://ClinicalTrials.gov/show/NCT00002263 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002126 A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection. https://ClinicalTrials.gov/show/NCT00002126 Completed NIH AIDS Clinical Trials Information Service NA
NCT00005893 Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders https://ClinicalTrials.gov/show/NCT00005893 Completed Office of Rare Diseases (ORD) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04460079 Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN https://ClinicalTrials.gov/show/NCT04460079 Completed Cinnagen 2019-09-07
NCT00059423 Natural History Study for BEN https://ClinicalTrials.gov/show/NCT00059423 Completed National Institutes of Health Clinical Center (CC) 2019-04-23
NCT03364257 iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients https://ClinicalTrials.gov/show/NCT03364257 Recruiting Pathoquest 2019-04-30
NCT03342365 Evaluation of Intestinal Bacterial and Fungal Translocation and Intestinal Microbiota in Febrile Neutropenic Patients in Pediatric Onco-hematology https://ClinicalTrials.gov/show/NCT03342365 Recruiting Centre Hospitalier Universitaire de Nīmes 2020-12-31
NCT03262584 Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients https://ClinicalTrials.gov/show/NCT03262584 Completed Karius, Inc. 2018-07-31
NCT03217721 Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit https://ClinicalTrials.gov/show/NCT03217721 Completed University Hospital, Brest 2017-09-19
NCT02912117 Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay https://ClinicalTrials.gov/show/NCT02912117 Completed Karius, Inc. 2018-02-28
NCT02906254 Early Antibiotic Discontinuation in FUO https://ClinicalTrials.gov/show/NCT02906254 Completed University Hospital, Brest 2015-09-30
NCT02866162 Screening for Genes in Patients With Congenital Neutropenia https://ClinicalTrials.gov/show/NCT02866162 Completed Centre Hospitalier Universitaire Dijon 2015-09-30
NCT02774850 Home Away From Home - Medical Outcomes https://ClinicalTrials.gov/show/NCT02774850 Completed Children’s Hospital of Philadelphia 2019-07-26
NCT02544230 Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT02544230 Completed Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne 2011-12-31
NCT02536599 Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia https://ClinicalTrials.gov/show/NCT02536599 Recruiting Assiut University 2020-07-31
NCT02272673 The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT02272673 Completed Ain Shams University 2013-08-31
NCT02178475 Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin’s Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy https://ClinicalTrials.gov/show/NCT02178475 Completed Amgen 2016-10-28
NCT01821456 Cologne Cohort of Neutropenic Patients (CoCoNut) https://ClinicalTrials.gov/show/NCT01821456 Recruiting University Hospital of Cologne 2050-12-31
NCT01813721 Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy. https://ClinicalTrials.gov/show/NCT01813721 Completed Amgen 2013-12-31
NCT01799421 Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy https://ClinicalTrials.gov/show/NCT01799421 Completed Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología 2014-12-31
NCT01706562 A Study of Empirical Antifungal Therapy With Itraconazole https://ClinicalTrials.gov/show/NCT01706562 Completed Janssen Korea, Ltd., Korea 2011-09-30
NCT01683370 Pediatric FN Definition 2012 Bern https://ClinicalTrials.gov/show/NCT01683370 Completed Swiss Pediatric Oncology Group 2013-08-31
NCT01574235 Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents https://ClinicalTrials.gov/show/NCT01574235 Completed Hospira, now a wholly owned subsidiary of Pfizer 2014-02-28
NCT01459653 Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor https://ClinicalTrials.gov/show/NCT01459653 Completed Sandoz 2013-08-31
NCT01431326 Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care https://ClinicalTrials.gov/show/NCT01431326 Completed Duke University 2019-11-30
NCT04448314 Study to Evaluate the Usability of PointCheck https://ClinicalTrials.gov/show/NCT04448314 Active, not recruiting Leuko Labs, Inc. 2021-02-28
NCT04250038 Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT04250038 Recruiting Universitaire Ziekenhuizen Leuven 2020-08-01
NCT04217811 Late Neutropenia in VLBW Preterm Babies https://ClinicalTrials.gov/show/NCT04217811 Recruiting Hillel Yaffe Medical Center 2020-12-31
NCT04134429 Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy https://ClinicalTrials.gov/show/NCT04134429 Completed University Hospital Inselspital, Berne 2020-01-13
NCT03968328 Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients https://ClinicalTrials.gov/show/NCT03968328 Recruiting M.D. Anderson Cancer Center 2020-12-31
NCT03798665 A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT03798665 Recruiting Affiliated Hospital of North Sichuan Medical College 2019-07-06
NCT03641131 Ampholipad Real-World Data in Taiwan https://ClinicalTrials.gov/show/NCT03641131 Completed Taiwan Liposome Company 2019-01-02
NCT03530072 Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients https://ClinicalTrials.gov/show/NCT03530072 Enrolling by invitation Karius, Inc. 2019-08-01
NCT03511820 A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever https://ClinicalTrials.gov/show/NCT03511820 Completed TTY Biopharm 2018-01-15
NCT03434795 Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy https://ClinicalTrials.gov/show/NCT03434795 Completed University Hospital, Lille 2017-05-31
NCT01060462 Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients https://ClinicalTrials.gov/show/NCT01060462 Completed Janssen Korea, Ltd., Korea 2009-02-28
NCT01021683 The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants https://ClinicalTrials.gov/show/NCT01021683 Completed Janssen Korea, Ltd., Korea 2010-07-31
NCT00945555 Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options https://ClinicalTrials.gov/show/NCT00945555 Completed Pfizer 2010-10-31
NCT00913042 Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia https://ClinicalTrials.gov/show/NCT00913042 Completed Assistance Publique - Hôpitaux de Paris 2009-04-30
NCT00883181 A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy https://ClinicalTrials.gov/show/NCT00883181 Completed Amgen 2009-10-31
NCT02956967 Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia https://ClinicalTrials.gov/show/NCT02956967 Completed Pfizer 2016-12-12
NCT02428114 A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study) https://ClinicalTrials.gov/show/NCT02428114 Completed Ottawa Hospital Research Institute 2017-03-31
NCT00816088 Diagnostic and Management Strategies for Invasive Aspergillosis https://ClinicalTrials.gov/show/NCT00816088 Completed King’s College Hospital NHS Trust 2011-12-31
NCT01669005 The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT01669005 Completed Centre Hospitalier Universitaire Vaudois 2008-12-31
NCT04005638 Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia https://ClinicalTrials.gov/show/NCT04005638 Recruiting University Hospital, Bordeaux 2022-02-28
NCT02856204 Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02856204 Completed Stanford University 2017-12-31
NCT03433560 An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®) https://ClinicalTrials.gov/show/NCT03433560 Recruiting Kyowa Kirin Korea Co., Ltd. 2021-06-30
NCT00503854 Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia https://ClinicalTrials.gov/show/NCT00503854 Completed M.D. Anderson Cancer Center 2018-04-05
NCT00462878 Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00462878 Completed PETHEMA Foundation NA
NCT00048971 Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT00048971 Completed Alliance for Clinical Trials in Oncology 2006-11-30
NCT00723073 Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia https://ClinicalTrials.gov/show/NCT00723073 Completed Brigham and Women’s Hospital 2008-05-31
NCT00008840 A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia https://ClinicalTrials.gov/show/NCT00008840 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02720679 Investigation of the Genetics of Hematologic Diseases https://ClinicalTrials.gov/show/NCT02720679 Recruiting St. Jude Children’s Research Hospital 2026-08-31
NCT02474550 Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma https://ClinicalTrials.gov/show/NCT02474550 Recruiting Ajou University School of Medicine 2018-12-31